Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Polke

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
BMJ Open Respiratory Research|December 25, 2025
Baseline characteristics from the EXCITING-ILD registryKatharina Buschulte, Hans-Joachim Kabitz, Lars Hagmeyer, et al.
Respiratory Research|January 4, 2024
Hospitalisation patterns in interstitial lung diseases: data from the EXCITING-ILD registryKatharina Buschulte, Hans-Joachim Kabitz, Lars Hagmeyer, et al.
Frontiers in Medicine|October 14, 2021
Management of Acute Exacerbation of Idiopathic Pulmonary Fibrosis in Specialised and Non-specialised ILD Centres Around the WorldMarkus Polke, Yasuhiro Kondoh, Marlies Wijsenbeek, et al.
The European Respiratory Journal|February 16, 2020
Acute exacerbation of idiopathic pulmonary fibrosis: international survey and call for harmonisationMichael Kreuter, Markus Polke, Simon L F Walsh, et al.
Respiration; International Review of Thoracic Diseases|February 5, 2026
Sex-specific phenotypes and outcomes in non‑IPF interstitial lung disease: results from the INSIGHTS‑ILD registryDirk Koschel, Francesco Bonella, Andreas Günther, et al.
JAMA Oncology|July 9, 2026
Consolidative Thoracic Radiotherapy With Atezolizumab Maintenance in Extensive-Stage Small Cell Lung Cancer: The Phase 2 TREASURE Randomized Clinical Trial (AIO-TRK-0320)Farastuk Bozorgmehr, Inn Chung, Rouven Behnisch, et al.
ERJ Open Research|June 10, 2025
Real-life characteristics and management of patients with fibrosing interstitial lung disease: INSIGHTS-ILD registryJürgen Behr, Michael Kreuter, Andreas U Guenther, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
BMJ Open Respiratory Research|December 25, 2025
Baseline characteristics from the EXCITING-ILD registryKatharina Buschulte, Hans-Joachim Kabitz, Lars Hagmeyer, et al.
Respiratory Research|January 4, 2024
Hospitalisation patterns in interstitial lung diseases: data from the EXCITING-ILD registryKatharina Buschulte, Hans-Joachim Kabitz, Lars Hagmeyer, et al.
Frontiers in Medicine|October 14, 2021
Management of Acute Exacerbation of Idiopathic Pulmonary Fibrosis in Specialised and Non-specialised ILD Centres Around the WorldMarkus Polke, Yasuhiro Kondoh, Marlies Wijsenbeek, et al.
The European Respiratory Journal|February 16, 2020
Acute exacerbation of idiopathic pulmonary fibrosis: international survey and call for harmonisationMichael Kreuter, Markus Polke, Simon L F Walsh, et al.
Respiration; International Review of Thoracic Diseases|February 5, 2026
Sex-specific phenotypes and outcomes in non‑IPF interstitial lung disease: results from the INSIGHTS‑ILD registryDirk Koschel, Francesco Bonella, Andreas Günther, et al.
JAMA Oncology|July 9, 2026
Consolidative Thoracic Radiotherapy With Atezolizumab Maintenance in Extensive-Stage Small Cell Lung Cancer: The Phase 2 TREASURE Randomized Clinical Trial (AIO-TRK-0320)Farastuk Bozorgmehr, Inn Chung, Rouven Behnisch, et al.
ERJ Open Research|June 10, 2025
Real-life characteristics and management of patients with fibrosing interstitial lung disease: INSIGHTS-ILD registryJürgen Behr, Michael Kreuter, Andreas U Guenther, et al.
Pageof 4